Myriad Settles With Quest In Cancer Gene Test Patent MDL
Myriad Genetics Inc. on Friday settled patent infringement litigation with Quest Diagnostics Inc., dismissing claims in Utah federal court alleging Quest infringed Myriad's patents for BRCA cancer gene testing, some of...To view the full article, register now.
Already a subscriber? Click here to view full article